ARHIMOTION

ARHIMOTIONARHIMOTION
ARHIMOTION

ARHIMOTION

AI solutions for mental health, addressing stress, burnout, and sleep disorders through automation therapy.

DR 0.7Speed 932023Inactive2
Rate

About

ARHIMOTION develops Physical AI-powered neuro-robotic therapeutics to address the global tension and emotional exhaustion caused by modern life. Their core product, the ADAMA Platform, combines robotics precision, AI personalization, and real-time biofeedback to deliver autonomous, non-pharmacological care for conditions like chronic insomnia and trauma. ARHIMOTION aims to democratize therapy, making expert-grade care accessible to everyone by removing staffing and geographic barriers.
Frequently asked

What does ARHIMOTION do?

ARHIMOTION develops Physical AI-powered neuro-robotic therapeutics to address the global tension and emotional exhaustion caused by modern life. Their core product, the ADAMA Platform, combines robotics precision, AI personalization, and real-time biofeedback to deliver autonomous, non-pharmacological care for conditions like chronic insomnia and trauma. ARHIMOTION aims to democratize therapy, making expert-grade care accessible to everyone by removing staffing and geographic barriers.

When was ARHIMOTION founded?

ARHIMOTION was founded in 2023.

What industry does ARHIMOTION operate in?

ARHIMOTION operates in Design Services, Freelancing, Startups, Creative Services, On-Demand Services, Small Business Support.

How many employees does ARHIMOTION have?

ARHIMOTION has approximately 2 people on record.

What is ARHIMOTION's current status?

ARHIMOTION's current operating status is: Inactive.

HEADCOUNT
2
DOMAIN RATING
0.7
New entrants in Creative Services
Last 90 days
4
New entrants
1.3
Per month
0.3
Per week

An entrant is a company tagged Creative Services whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.

Comments

No comments yet. Be the first to share your take.